Plans to restrict open market access to tuberculosis medicines
With cases of
drug-resistant tuberculosis
on the rise in India, authorities are set to tighten open market access to newer
anti-TB drugs
Bedaquiline and
Delamanid
, which went off patent last year.
The Central TB division-which is under the health ministry-had written to the
Central Drugs Standard Control Organisation
(CDSCO) citing "access risks" that are leading to indiscriminate use, potentially increasing cases of treatment failure and resistance to these drugs. The patents for
Bedaquiline
and Delamanid expired last year, paving the way for pharmaceutical companies to manufacture the molecule. The drugs eventually became available in the market.
The newer anti-TB drugs, including Bedaquiline, Delamanid, Pretomanid and Rifapentine, are available in the market.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
Chuck Norris Begs Seniors: Avoid These 3 Foods Like The Plague
Roundhouse Provisions
Learn More
Undo
This week, the matter was taken up by the
Drugs Consultative Committee
(DCC), an expert committee under the CDSCO, which suggested that licences be issued on the condition that the use of Bedaquiline, Delamanid, Pretomanid and Rifapentine will be as per Standards of TB Care in India (STCI), and that there should be conditional access through the
National TB Elimination programme
(NTEP).
The experts also said that if such a condition is not mentioned in the existing licences, it should be modified accordingly. It also said the label on the container of the drug, as well as the packaging, should bear the warning-"For use in NTEP", which shall be in a box with a red background.
Live Events
"The DCC, after detailed deliberation, agreed with the proposal to issue suitable guidance to all state licensing authorities to address the issue uniformly. The DCC also recommended that in case some SLAs had already issued the manufacturing licence for such a product, they can issue separate letters for communicating the above conditions," the minutes of the meeting suggested.
ET has seen a copy of the minutes.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
2 hours ago
- Time of India
Telangana to frame organ-specific transplant rules, eyes stricter monitoring and tissue matching rules
HYDERABAD: After the Telangana assembly recently adopted the central Transplantation of Human Organs and Tissues Act of 1994, the state govt is now establishing additional regulations. A major focus is on having specific regulations for each type of organ to prevent exploitation, illegal activities and ensure that organs are accessible to ordinary individuals, stated sources Following the adoption of the central Act, a team of officials visited Tamil Nadu, AP, Gujarat, and Maharashtra to study their organ transplant rules. One of key considerations before officials is making tissue matching compulsory for kidney transplants. Kidney transplants were conducted solely on matching blood groups. You Can Also Check: Hyderabad AQI | Weather in Hyderabad | Bank Holidays in Hyderabad | Public Holidays in Hyderabad The state is also in the process of replacing its existing Jeevandan programme with the State Organ and Tissue Transplant Organisation. Among all the states, officials found the regulations in Tamil Nadu suitable for Telangana as the govt there controls organ donations. It was also observed that though rules are good in Andhra Pradesh, monitoring was missing. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Explore opções de cruzeiros confortáveis concebidos para viajantes seniores Cruzeiros | Links Patrocinados Busque agora Undo Experts highlighted the "Andhra link" to many illegal organ rackets in Telangana, emphasising the need for stricter monitoring in Andhra Pradesh. One of the major considerations for Telangana in introducing these new rules is the preservation of markers for kidney recipients and donors. These markers are vital for the success of organ transplants. Tissue typing, or HLA (Human Leukocyte Antigen) typing, is an essential test in kidney transplantation that determines compatibility between the donor and recipient. It identifies specific proteins on cells that help the body distinguish between "self" and "non-self," playing a critical role in preventing organ rejection. By matching these antigens, doctors can assess the risk of rejection and select the most compatible donor-recipient pair, ensuring a successful transplant outcome. Authorities added that while this process is currently not being implemented, it could be introduced in the future.
Time of India
3 hours ago
- Time of India
Cancer Daily Health Horoscope Today, June 27, 2025: Don't rush the outcome — nurture the process
Cancer, daily horoscopes await your discovery according to how mighty planets act on your health and vitality. Get helpful insights to coordinate your day with clarity and confidence. Maintain your balance and bask in the good cosmic vibes. Today reminds you that true growth takes time, so avoid rushing results. Focus on nurturing each step of your journey with patience and care. Trust the process even if progress seems slow or invisible. Your consistent efforts are planting seeds that will bloom in their own perfect time. Embrace patience and stay gentle with yourself. The outcome will be worth the wait. Cancer Health Horoscope Today Your health benefits when you maintain steady care and avoid impatience. Don't push yourself to recover or improve too quickly. Gentle exercise, proper nutrition, and restful sleep support your healing. Listen to your body's needs without frustration. Small daily habits nurture your wellbeing and prepare you for lasting vitality. Patience in health matters brings sustainable energy and strength. Cancer Wellness Horoscope Today Wellness depends on nurturing your mind and heart through regular self-care. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like 5 Books Warren Buffett Wants You to Read In 2025 Blinkist: Warren Buffett's Reading List Undo Avoid stressing over quick fixes or sudden changes. Consistency in meditation, relaxation, and healthy habits improves your mood and balance. Being kind to yourself during this process creates peace and resilience. Trust that steady care nurtures your whole being and brings deep wellness. Cancer Love Horoscope Today Love grows stronger when you focus on nurturing relationships patiently. Avoid forcing progress or rushing conversations. Small acts of care, kindness, and understanding deepen bonds. If single, trust that love unfolds in its own time. Being gentle with yourself and others fosters trust and intimacy. Nurturing the process creates lasting and meaningful connections. Cancer Career Horoscope Today Career progress comes through steady effort and patience. Avoid pushing for immediate results or stressing over deadlines. Focus on doing your best with each task and trust that growth will follow. Your consistent work ethic builds a strong foundation for future success. Nurturing your professional journey patiently opens doors to long-term rewards. Cancer Money Horoscope Today Money and finance improve when you nurture your resources carefully. Avoid hasty investments or impulsive spending. Consistent saving and thoughtful planning bring financial security. Patience with money matters creates stability and peace of mind. Trust that slow, steady growth leads to lasting abundance. Nurturing your financial health today prepares you for a secure tomorrow. Cancer Affirmation Today: I nurture each step and trust the journey. Discover everything about astrology at the Times of India , including daily horoscopes for Aries , Taurus , Gemini , Cancer , Leo , Virgo , Libra , Scorpio , Sagittarius , Capricorn , Aquarius , and Pisces .
Time of India
4 hours ago
- Time of India
Obesity and ovarian cancer: The silent link every woman needs to know
Ovarian cancer is among the deadliest gynaecologic cancers, usually diagnosed late because of its nonspecific presentation. Although genetic predisposition and reproductive factors are established risk factors, increasing evidence points towards obesity as an important, modifiable risk factor. As obesity is increasing worldwide, its association with ovarian cancer has become increasingly prominent for prevention, early detection, and better therapeutic results. The growing obesity burden Obesity, which is a body mass index (BMI) of ≥30 kg/m², has become an epidemic in all parts of the globe. The World Health Organization (WHO) states: Over 1 billion people in the world were obese in 2022. Adult obesity in the US was 42.4% as of 2020, which is a steep rise from 30.5% in 2000 (CDC). The trend is strongly relevant to cancer incidence, including ovarian cancer. Ovarian cancer: The silent killer Ovarian cancer is the fifth most common reason for female cancer-related deaths in the United States and is responsible for more female reproductive cancer deaths than any other type. The American Cancer Society estimates: In 2024, an estimated 19,680 women in the United States will develop ovarian cancer. About 12,740 deaths will occur due to the disease. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Top Australian Doctors Stunned By New German Hearing Aid That Costs Less Than Dinner Out Top Trending News Today Learn More Undo The five-year survival rate for ovarian cancer is typically low, just 49%, largely because it is typically diagnosed late. Biological mechanisms that connect obesity and ovarian cancer 1. Overproduction of estrogen Excess fat tissue results in peripheral conversion of androgens to estrogens, particularly after menopause. Estrogen stimulates growth in cells of the ovary, potentially increasing the chance of mutation and tumor formation. 2. Inflammation Obesity causes chronic inflammation with elevated cytokine levels, including TNF-α, IL-6, and CRP. Chronic inflammation results in DNA damage and may cause tumor development. 3. Insulin Resistance and IGF-1 Obesity is associated with insulin resistance, leading to raised levels of insulin and insulin-like growth factor-1 (IGF-1). Both exhibit mitogenic and anti-apoptotic properties, which may promote the survival and growth of ovarian tumor cells. 4. Adipokines and Leptin Adipokines are hormones secreted by fat tissue. Among them, leptin is increased in obesity and has been reported to promote proliferation of cancer cells and ovarian tumor angiogenesis. Epidemiological evidence Multiple large-scale studies have measured the association of BMI and risk of ovarian cancer: A meta-analysis in Cancer (2013) of more than 20 cohort studies concluded that an increase of 5 units in BMI was linked to a 10% higher risk of ovarian cancer. A WCRF study found that increased body fatness is "likely" to be a cause of ovarian cancer, particularly for non-serous subtypes. Obese ovarian cancer patients also experience worse prognosis, including: Increased disease recurrence following treatment. Decreased overall survival, with stage and treatment type controlled for. Increased rates of surgery and chemotherapy complications. Implications for Prevention and Management From evidence, obesity is a modifiable risk factor for ovarian cancer. Prevention measures are: Diet and exercise weight control. Public health prevention policies against obesity from a young age. Risk stratification and screening of high-BMI groups. In practice, oncologists will have to modify the treatment of obese patients, including individualized chemotherapy dosing and more aggressive surgery to improve outcomes. Obesity is not just a cosmetic issue—it is a clinical and biological risk factor and progression driver for ovarian cancer. As the epidemic of obesity marches forward, so must the need to incorporate prevention, awareness, and targeted treatment strategies into women's health policy. Prevention of obesity has the potential to dramatically decrease the burden of ovarian cancer and enhance survival in thousands of women worldwide. Dr Vishnu Agarwal, Surgical Oncologist, Saifee Hospital, Mumbai
